Craigslist Car Scams Are on the Rise, Especially in Midwest
An insurance group is warning consumers of a widespread scam in which fraudsters are buying cars on Craigslist with bogus checks.
The National Insurance Crime Bureau has identified nearly 100 instances throughout the Midwest of Craigslist car sales in which the buyers used fake bank checks.
“These scams are well organized and have all the appearances of being legitimate,” NCIB President and CEO Joe Wehrle said in a statement. “But in the end, the criminal gets the car and the sellers or their financial institutions are left on the hook for thousands of dollars still owed on the car.”
Related: A New Vicious Scam Targets Desperate Homeowners
The scam appears to be especially prevalent in states where vehicle owners retain the title despite an outstanding lien. NCIB, a nonprofit supported by the insurance industry, advises car sellers never to sign over the title until they have the money for the sale in hand, even if that means waiting a week or more for a check to clear.
Craigslist offers its own list of tips to avoid scams. Remember, the online marketplace offers no guarantees regarding items bought or sold via its site and little recourse if you are the victim of a scam.
The site’s No. 1 tip is to do all transactions in person. A growing number of police stations now offer dedicated space for people meeting in person for transactions they’ve agreed to online.
Those with information about insurance fraud or vehicle theft can anonymously report it by calling 800-835-6422 or texting keyword “fraud” to TIP411.
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
